BIOTIA-DX RESISTANCE Achieved the Best Antimicrobial Resistance Phenotype Prediction Accuracy at CAMDA 2025

We have developed BIOTIA-DX RESISTANCE (BDXR), a bioinformatic tool for predicting antimicrobial resistance (AMR) from whole genome sequencing of microbial isolates. BDXR achieved the best accuracy of any submission to the CAMDA 2025 AMR Challenge. This year’s challenge focused on predicting AMR phenotype which is a more complex problem than the detection of AMR marker genes, the focus of some prior years. BDXR achieved an overall F1 score of 89% on the training set and 84.1% on the challenge test set. Accuracy varied across the 9 species and drug pairs in the competition from an F1 score of 98.4% ( Campylobacter jejuni , tetracycline) to 78.5% ( Pseudomonas aeruginosa , cefatzidime). BDXR is based on curation of global datasets, machine learning-based predictions from input data, and highly stringent prepreprocessing of input data and databases.